Hospitals

Breadcrumb trail

Need Help or want to give your feedback?

Whether you’re having trouble with your account, or would like to make a suggestion, Canadian Blood Services offers you quick and convenient options to troubleshoot or get in touch. Contact us via live chat, consult our FAQ, send an email feedback@blood.ca, or give us a call at 1 888 2 DONATE (1-888-236-6283).

Customer Letter Archive

Archives: 2007 - 2015

Please note: The following Customer Letters, in electronic format, do not replace the print version that you receive from your local Canadian Blood Services site. The print version must be retained as your file copy.


2015 2014 2013 2012 2011 2010 2009 2008 2007

2015 

Letter # Date Title
Customer Letter 2015-33 (PDF) 2015-12-17

INFORMATION ONLY
Hospital facilities that use Winnipeg platelet immunology services only

Customer Letter 2015-33 (PDF)   |   Platelet Immunology Requisition

Customer Letter 2015-32 (PDF) 2015-12-09

INFORMATION ONLY
Hospital and Canadian Blood Services Inventory Reporting

Customer Letter 2015-32 (PDF)

Customer Letter 2015-31 (PDF) 2015-12-04

INFORMATION ONLY
Use of 2016 Pool Number Labels in 2015

Customer Letter 2015-31 (PDF)

Customer Letter 2015-30 (PDF) 2015-12-02

INFORMATION ONLY
Re-introduction of IGIVnex®

Customer Letter 2015-30 (PDF)   |   Grifols Canada Letter

Customer Letter 2015-29 (PDF) 2015-11-10

INFORMATION ONLY
Job Aid: Phenotype Information Red Blood Cell Label and Tags - French Correction

Customer Letter 2015-29 (PDF)

Customer Letter 2015-28 (PDF) 2015-10-08

INFORMATION ONLY
VariZIG® Liquid Formulation

Customer Letter 2015-28 (PDF)   |   Emergent BioSolutions Letter

Customer Letter 2015-27 (PDF) 2015-10-05

INFORMATION ONLY
Corporate Announcement: Appointment: Chief Supply Chain Officer

Customer Letter 2015-27 (PDF)

Customer Letter 2015-26 (PDF) 2015-09-29

INFORMATION ONLY
Implementation of Donor Red Cell Phenotype Tags

Customer Letter 2015-26 (PDF)

Customer Letter 2015-25 (PDF) 2015-09-28

ACTION REQUIRED
Diagnostic Services Toronto Centre - Reference Laboratory Requisition Change

Customer Letter 2015-25 (PDF)   |   Request For Serological Investigation - Toronto

Customer Letter 2015-24 (PDF) 2015-09-03

INFORMATION ONLY
New Insulated Shipping Containers for Hospital Deliveries - Edmonton Production and Distribution Site

Customer Letter 2015-24 (PDF)   |   ISC Packing Configurations   |   Instructions for Returning ISCs to Canadian Blood Services   |   SDS for Phase Change Materials   |   List of Current ISC Supplies and Suppliers  

Customer Letter 2015-23 (PDF) 2015-08-20

INFORMATION ONLY
Octapharma Product Updates: Octaplex® 1000 IU & Octaplasma®

Customer Letter 2015-23 (PDF)   |   Octapharma Letter   |   Octapharma Letter - Octaplex®

Customer Letter 2015-22 (PDF) 2015-08-11

INFORMATION ONLY
Changes to Requesting HLA/HPA Selected Apheresis Platelets

Hospitals Serviced by Canadian Blood Services Winnipeg Crossmatch Lab Only

Customer Letter 2015-22 (PDF)

Customer Letter 2015-21 (PDF) 2015-08-11

INFORMATION ONLY
Changes to Requesting HLA/HPA Selected Apheresis Platelets

Customer Letter 2015-21 (PDF)

Customer Letter 2015-20 (PDF) 2015-07-20

INFORMATION ONLY
Canadian Blood Services Blood Group Genotyping Services

Customer Letter 2015-20 (PDF)   |  Requisition for Blood Group Genotyping (NIRL)  |   Request for RHD Genotyping   |   RHD Report Example   |   ID CORE XT Sample Report

Customer Letter 2015-19 (PDF) 2015-07-07

INFORMATION ONLY
Important update on Pan Am and Parapan Am Games

This Customer Letter impacts those hospitals that are served from Brampton distribution centre and/or utilize the Diagnostic Services Laboratory located at our Canadian Blood Services 67 College Street site.

Customer Letter 2015-19 (PDF)

Customer Letter 2015-18 (PDF) 2015-06-24

INFORMATION ONLY
Enhancements to Hospitals Section of www.blood.ca

Customer Letter 2015-18 (PDF)

Customer Letter 2015-17 (PDF) 2015-06-16

INFORMATION ONLY
Release of the Red Blood Cells, Leukocytes Reduced (LR), Plasma Components and Platelets Circulars With Updates to West Nile Virus Testing at Canadian Blood Services
And Release of the Red Blood Cells, Leukocytes Reduced (LR) Circular Updated with the Addition of a Pooled Red Blood Cell Component for Neonate Exchange Transfusion

Customer Letter 2015-17 (PDF)

Customer Letter 2015-16 (PDF) 2015-06-08

INFORMATION ONLY
Changes to Plasma Protein Products

Customer Letter 2015-16 (PDF)   |   Kogenate letter   |   NiaStase letter

2015-15 (PDF) 2015-05-13

INFORMATION ONLY
CSL Behring Product Updates: RiaSTAP™ with Diluent and Berinert® 1500 IU

Customer Letter   |   CSL Behring Letter  - RiaSTAP  |   CSL Behring Letter  - Berinert

2015-14 (PDF) 2015-05-05

INFORMATION ONLY
Changes to labelling of Apheresis Plasma Products

Customer Letter   

2015-13 (PDF) 2015-05-04

INFORMATION ONLY
Baxter name change to Baxalta

Customer Letter   |   Baxter Letter

2015-12 (PDF) 2015-04-27

INFORMATION ONLY
Improvements to Donor Red Cell Phenotype Tags

Customer Letter  

2015-11 (PDF) 2015-03-30

INFORMATION ONLY
Important Information Regarding Availability of Immune Globulin Products for 2015-2016

Customer Letter  

2015-10 (PDF) 2015-03-26

INFORMATION ONLY
Reporting Tretten® Utilization

Customer Letter  

2015-09 (PDF) 2015-03-23

INFORMATION ONLY
Hizentra® Biweekly Dosing Regimen

Customer Letter  | CSL Behring Letter

2015-08 (PDF) 2015-02-17

INFORMATION ONLY
Revisions to Canadian Guidelines for the Uniform Labelling of Blood and Blood Components Using ISBT 128

Customer Letter

2015-07 (PDF) 2015-02-12

INFORMATION ONLY
Octaplasma®, Pathogen Inactivated available for distribution in Canada

Customer Letter  |  Octapharma Letter  | Availability Letter

2015-06 (PDF) 2015-02-09

INFORMATION ONLY
Octalbin® (Human Albumin) available for distribution in Canada

Customer Letter  |  Octapharma Letter

2015-05 (PDF) 2015-01-30

INFORMATION ONLY
Important update on labour agreement at Canadian Blood Services

Customer Letter  

2015-04 (PDF) 2015-01-29

INFORMATION ONLY
2014 Hospital Survey Results

Customer Letter  

2015-03 (PDF) 2015-01-26

INFORMATION ONLY
Update on labour negotiations at Canadian Blood Services

Customer Letter  

2015-02 (PDF) 2015-01-08

INVENTORY ALERT
Important Information Regarding Kogenate® FS

Customer Letter    Announcement

2015-01 (PDF) 2015-01-05

INVENTORY ALERT
Important Information Regarding Factor XI Concentrate

Customer Letter

 

2014

Letter # Date Title
2014-22 (PDF) 2014-12-23

INFORMATION ONLY
Important update on potential labour disruption at Canadian Blood Services

Customer Letter

2014-21 (PDF) 2014-12-18

INFORMATION ONLY
Holiday Message and Inventory Advisory

Customer Letter

2014-20 (PDF) 2014-12-04

INFORMATION ONLY
UPDATE to the Investigation into IGIVnex® (Immune Globulin Intravenous (Human), 10% Lots: Quarantined and Recalled

2014-19 (PDF) 2014-11-27 ACTION REQUIRED
Important Information Regarding Ordering of OctaplasmaTM Solvent Detergent Treated Human Plasma (SD Plasma)
2014-18 (PDF) 2014-11-04 INFORMATION ONLY
Letter to Atlantic Canada Hospitals regarding NAIT (Neonatal Alloimmune Thrombocytopenia) Testing

Platelet Immunology Requisition Form 
Sample Shipping Instructions - (NAIT) Testing 
 
2014-17 (PDF) 2014-11-04 INFORMATION ONLY
Introduction of New Whole Blood Collection Bags and Pooled Platelets Bag

Macopharma Platelet Bag Port Opening Procedure

Implementation of new blood bags
 
2014-16 (PDF)  2014-09-29 ACTION REQUIRED
Red cell inventory advisory and request for hospital inventory reporting
2014-15 (PDF)  2014-09-25 INFORMATION ONLY
Hospital Adverse Reaction Reporting to Canadian Blood Services
2014-14 (PDF)  2014-09-22 INFORMATION ONLY
O Rh negative Red Blood Cell Utilization and Inventory Management Best Practices
2014-13 (PDF)  2014-09-18

INFORMATION ONLY
Revised Shelf life and Storage Requirements NiaStase RT®

Customer Letter

2014-12 (PDF) 2014-08-27

INFORMATION ONLY
Implementation of a National Hospital Customer Feedback Form

HCF-Form 

2014-11 (PDF)  2014-07-24

INFORMATION ONLY
Important Information Regarding Indication for use of Privigen® for CIDP

CSL Behring Letter 

2014-10 (PDF)  2014-07-21 INFORMATION ONLY
NAC Companion Document to: “Red Blood Cell Transfusion: A Clinical Practice Guideline from the AABB”
2014-09 (PDF)  2014-07-04

INFORMATION ONLY
UPDATE to the Investigation into IGIVnex® (Immune Globulin Intravenous (Human), 10%)
Lots: Quarantined and Recalled

Grifols Letter 

2014-08 (PDF)  2014-06-12 INFORMATION ONLY
Revised Recommendations for the Use of Prothrombin Complex Concentrates
2014-07 (PDF) 2014-05-15 INFORMATION ONLY
Improvements to the Blood and Plasma Protein Products Return Process

2014-06 (PDF)

2014-05-12 INFORMATION ONLY
Short Dated Product Process

2014-05 (PDF)

2014-04-22 Action Required (not applicable for hospitals in the provinces of British Columbia and Manitoba)
Blood Component and Product Disposition System Implementation

2014-04 (PDF)

2014-04-17

INFORMATION ONLY
Launch of Corifact 250 and Corifact 1250 (Factor XIII Concentrate, Human)
Corifact 250 and Corifact 1250 (Factor XIII Concentrate, Human) Letter (PDF)

2014-03 (PDF)

2014-03-24

INFORMATION ONLY
IGIVnex® (Immune Globulin Intravenous (Human), 10%) Lots: Quarantined and Recalled
Grifols update letter (PDF)

2014-02 (PDF)

2014-02-20

INFORMATION ONLY
Upgrade of Blood Group Genotyping to Progenika ID CORE XT Assay
Red Blood Cells Typing Report (PDF)

2014-01 (PDF)

2014-02-18

INFORMATION ONLY
Important Information Regarding Availability of Immune Globulin Products for 2014-2015
Octagam® 10% (PDF)

2013

Letter # Date Title
2013-31 (PDF) 2013-12-19

Information Only

Availability of Gammagard Liquid Immune Globulin Intravenous (Human), [IGIV] 10%

2013-30 (PDF) 2013-12-12

Information Only
(not applicable for hospitals in the provinces of British Columbia and Manitoba)

Hospital Disposition Improvement Initiative – Changes to the Hospital Blood Component Report

Web-Based Disposition System Data Entry Field Definitions (PDF)

2013-29 (PDF) 2013-12-03

Information Only
PROGESA Blood Management Software Upgrade

Attachment 1 of 2 (PDF)

Attachment 2 of 2 (PDF)

2013-28 (PDF) 2013-11-12

Information Only
Changes to Plasma Protein Products Distributed by Canadian Blood Services

Canadian Blood Services Hizentra 50mL DCL (PDF)

Dear clinician ATIII (PDF)

Temp Change Notice (PDF)

2013-27 (PDF) 2013-11-07

Information Only
Expiry Date of ADVATE 3000 IU Kit Lot# LE01N535AE

Expiry Date of ADVATE 3000 IU Kit Lot# LE01N535AE letter (PDF)

2013-26 (PDF) 2013-10-09

Manitoba Only
RESCIND NOTIFICATION

Changes to the Facility Return Process

2013-26 (PDF) 2013-10-01

RESCIND NOTIFICATION

Changes to the Facility Return Process

2013-25 (PDF) 2013-09-16 Important Information
Confirmed Implementation Date and Consolidation of Washed Red Blood Cell Sites with Implementation of Extended Expiry
2013-24 (PDF) 2013-08-29

INFORMATION ONLY
Delay in Launch of CINRYZE™,(C1 inhibitor [human])

Supplier Letter ViroPharma re: Cinryze (PDF)

2013-23 (PDF) 2013-08-14 INFORMATION ONLY
Babesiosis and Hepatitis E Seroprevalence Study
2013-22 (PDF) 2013-07-22

IMPORTANT INFORMATION
Washed Red Blood Cell with Extended Expiry Implementation

Attachment 1 Washed Red Cell Product Bag with Blank Label (PDF)

Attachment 2 Washed Red Cell Label with SAGM Added (PDF)

Attachment 3 Information Tag with Accurate Volume (PDF)

Attachment 4 Information Tag Indicating Extra Wash (PDF)

Attachment 5 Information Tag with Accurate Volume and Extra Wash (PDF)

Attachment 6 Special Request Order Form (PDF)

Attachment 7 Formulaire de commande spéciale (Culot Globulaire) (PDF)

2013-21 (PDF) 2013-07-18

IMPORTANT INFORMATION
Launch of CINRYZE™,(C1 inhibitor [human])

New therapeutic option for prevention of hereditary angioedema (HAE) attacks now available through Canadian Blood Services (PDF)

2013-20 (PDF) 2013-07-11

IMPORTANT INFORMATION
Privigen® 40g vial size available for distribution in Canada

Privigen® 40g vial size available for distribution in Canada (PDF)

2013-19 (PDF) 2013-06-13

IMPORTANT INFORMATION
Requisition For Blood Group Genotyping (Patient) NIRL/
Requisition For Antibody Investigation NIRL

Requisition for Blood Group Genotyping (Patient)
National Immunohematology Reference Laboratory (NIRL) (PDF)

REQUISITION FOR ANTIBODY INVESTIGATION
National Immunohematology Reference Laboratory (NIRL) (PDF)

2013-18 (PDF) 2013-05-27 Information Only
New Contact Information for all Atlantic Medical Offices at Canadian Blood Services
2013-17 (PDF) 2013-05-15

Information Only
Change to Canadian Blood Services Tamper Indicator Device - All Hospitals EXCEPT BC & Yukon Hospitals

2013-16 (PDF) 2013-05-08

Information Only
Changes to Plasma Protein Products Distributed by Canadian Blood Services

New pre-filled diluent Syringe with Kogenate® FS (PDF)

Privigen® 2.5g vial size available for distribution in Canada (PDF)

What's New With BeneFIX®? New Indication. New Vial Size. (PDF)

Addition of Ancillaries to Berinert® Package (PDF)

2013-15 Update (PDF) 2013-05-16

Information Only
Circular of Information – Release of the Red Blood Cells LR SAGM Added

Updates to the Frozen & Deglycerolized Red Blood Cell Processes at Canadian Blood Services,
April 2013 Version

2013-15 (PDF) 2013-05-02

Information Only
Circular of Information – Release of the Red Blood Cells LR SAGM Added

Updates to the Frozen & Deglycerolized Red Blood Cell Processes at Canadian Blood Services
April 2013 Version

2013-14 (PDF) 2013-05-01

Information Only
Canadian Blood Services Logistics Delivery Pilot - Dartmouth Production and Distribution Site;

2013-13 (PDF) 2013-04-24

Information Only
Washed Red Blood Cells With Extended Expiry ISBT 128 Sample Labels and Product Codes

Attachments

Product Codes and Label Text (PDF)

WASH RBC LR SAGM 2-1 (PDF)

WASH RBC LR SAGM 2-2 (PDF)

WASH RBC LR SAGM 2-3 (PDF)

WASH RBC LR SAGM 2-4 (PDF)

2013-12 (PDF) 2013-04-22

Information Only
Launch of octagam® 10% Immune Globulin Intravenous (Human)

Octagam Canadian Blood Services HCP introduction letter (PDF)

Canadian Blood Services Octagam product profile letter (PDF)

2013-11 (PDF) 2013-04-11

Information Only
RiaSTAP and Haemocomplettan® P Distribution

2013-10 Update II (PDF) 2013-06-06 Information Only
Phenotype Tag L040995
2013-10 Update (PDF) 2013-05-09 Information Only
Phenotype Tag L040995
2013-10 (PDF) 2013-04-08

Information Only
Improvements to Donor Red Cell Phenotype Tags

Phenotype Information Provided to Hospitals by Canadian Blood Services Red Blood Cell Label and Tags (PDF)

2013-09 (PDF) 2013-03-18 Information Only
2012 Hospital Satisfaction Survey Summary
2013-08 (PDF) 2013-03-11 Information Only
Important Information Regarding Availability of Immune Globulin Products and Prothrombin Complex Concentrates for 2013-2014
2013-07 (PDF) 2013-02-13

Information Only
Product Labeling Change for Deglycerolized Red Blood Cells including Circular of Information Change and Labeling Change for Frozen Red Blood Cells

Attachment #1 (PDF)

Attachment #2 (PDF)

2013-06 (PDF) 2013-02-12

Information Only
Tretten® Distribution

INTRODUCING TRETTEN®: A RECOMBINANT COAGULATION FXIII-A21* (PDF)

Tretten® (catridecacog) – A recombinant factor XIII A-subunit1 (PDF)

2013-05 (PDF) 2013-02-11

Action Required
Canadian Blood Services’ Saint John Site Move to Dartmouth Facility

2013-04 (PDF) 2013-01-22

Information Only
RiaSTAP Distribution

RiaSTAPTM (Fibrinogen Concentrate (Human), FCH) (PDF)

2013-03 (PDF) 2013-02-07 Information Only
Emergency Framework - Synopsis for Triage Teams
2013-02 (PDF) 2013-01-21 Information Only
Recombinant Factor VIII Transition
2013-01 (PDF) 2013-01-07 Action Required
Canadian Blood Services’ Halifax Site Move to Dartmouth Facility

Back to top

2012

Letter # Date Title
2012-35 (PDF) 2012-12-20 Change to the Canadian Blood Services Tamper Indicator Device - BC & Yukon Hospitals Only
2012-34 (PDF) 2012-12-05 Information Only
Release of the Circulars of Information October 2012 Version
2012-33 (PDF) 2012-10-04 Information Only
Plasma Protein Products Packing Slip Reduction
2012-32 (PDF) 2012-08-07

Requisition for Blood Group Genotyping (Patient)
Requisition for Antibody Investigation

Requisition for Blood Group Genotyping (Patient) (PDF)

Requisition for Antibody investigation (PDF)

2012-31 (PDF) 2012-07-30 Information Only
Important Information Regarding the Introduction of Octaplasma™
(Solvent Detergent (S/D)Treated Human Plasma)

2012-30 (PDF)

2012-07-19

Information Only
Factor VII Critical Supply Update

RE: Factor VII Critical Supply Update (PDF)

2012-29 (PDF) 2012-07-16

Information Only
Notification on GAMMAGARD LIQUID 30g Lot LE12M055AB

RE: Notification on GAMMAGARD LIQUID 30g Lot LE12M055AB (PDF)

2012-28 (PDF) 2012-06-28

Information Only
Changes to the Special Request Order Form and the Blood Component Order Form

Blood Component Order Form (PDF)

Special Request Order Form (RBC) (PDF)

2012-27 (PDF) 2012-06-27

Information Only
Factor VII Critical Supply Notice

RE: Factor VII Critical Supply Notice (PDF)

2012-25 (PDF) 2012-06-14

Information Only
Health Canada Endorsed Important Safety Information on HepaGam B® (Hepatitis B Immune Globulin {Human} Injection)

NOTICE TO HOSPITALS Health Canada Endorsed Important Safety Information on HepaGam B® (Hepatitis B Immune Globulin [Human] Injection) (PDF)

2012-24 (PDF) 2012-06-05 Information Only
Canadian Blood Services’ London Site Move to Brampton Facility;
2012-23 (PDF) 2012-06-04

Information Only
Alburex®, Albumin (Human)
Changes to Temperature Storage

Alburex DCL storage (PDF)

2012-22 (PDF) 2012-05-30

Information Only
Health Canada Endorsed Important Safety Information on Privigen®, Immune Globulin Intravenous (Human)

Health Canada Endorsed Important Safety Information on Privigen®, Immune Globulin Intravenous (Human) (PDF)

2012-21 (PDF) 2012-05-24

Information Only
Xyntha® Solofuse™

Xyntha® Solofuse™

2012-17 Correction (PDF) 2012-05-23 CORRECTION
Information Only

Important Information Regarding the Introduction of Octaplasma™
(Solvent Detergent (S/D)Treated Human Plasma)
2012-20 (PDF) 2012-05-17

Discontinuation of Routine Platelet Yield Testing of Apheresis Platelets

Notification of Apheresis Platelet Yield (PDF)
2012-19 (PDF) 2012-05-16 Circular of Information – Quality Control (QC) Criteria for Red Blood Cells LR SAGM added
2012-18 (PDF) 2012-05-14

Corporate Name Change for Wyeth & Extended Temperature Storage for BeneFIX® Coagulation Factor IX (Recombinant)

SJ Canadian Blood Services Letter BenXYN (PDF)

Introducing the convenience of extended room temperature storage for BeneFIX (PDF)

2012-17 (PDF) 2012-05-01

Important Information Regarding the Introduction of Octaplasma™
(Solvent Detergent (S/D)Treated Human Plasma)

Important treatment advance in Transfusion Medicine – Octaplasma® is now available in Canada (PDF)

Attachment #1 - Solvent Detergent Plasma Request Form (PDF)

Attachment #2 - Hospital Solvent Detergent Plasma Disposition Report (PDF)

Attachment #3 - Octaplasma Labeling First 6 Lots (PDF)

Attachment #4 - Octaplasma Labeling Future Labels (PDF)

2012-16 (PDF) 2012-05-01 Change to the Shell of the Canadian Blood Services Shipping Containers
2012-15 (PDF) 2012-04-30 Revised dates for moves of Hamilton and London sites to Brampton
2012-14 (PDF) 2012-04-18 Update to the Phenotype Labelling Bug on the Red Blood Cell Component;
2012-13 (PDF) 2012-04-12 Recommendations for the Notification of Recipients of a Blood Component Recall
2012-12 (PDF) 2012-04-03 Important Information Regarding Availability of Immune Globulin Products for 2012-2013
2012-11 (PDF) 2012-03-12 Canadian Blood Services’ Hamilton Site Move to Brampton Facility
2012-10 (PDF) 2012-03-08

Changes to Plasma Protein Products Distributed by Canadian Blood Services

COAGULATION FACTOR Comparison Table (PDF)

Important treatment advance in von Willebrand disease (VWD) care - wilate® is now approved in Canada for VWD patients. (PDF)

New Enhanced Reconstitution device for GAMMAGARD S/D (PDF)

wilate®, now available in convenient 500 IU and 1000 IU vials of both FVIII and VWF per vial (PDF)

ADVATE 2mL SWFI for 250IU and 500IU approved for distribution in Canada (PDF)

2012-09 (PDF) 2012-03-07 IMPORTANT INFORMATION REGARDING PATIENT IgA/Anti-IgA TESTING REQUESTS

 

PATIENT REQUEST FOR IgA/ANTI-IgA TESTING FORM (PDF)

2012-08 (PDF) 2012-02-29 Recommendations for Use of Prothrombin Complex Concentrates
2012-07 (PDF)

2012-02-27

2011 Hospital Satisfaction Survey Summary
2012-06 (PDF) 2012-02-21 Expanded Use of the Consignee (Customer) Notification Form
2012-02 Correction (PDF) 2012-01-30 CORRECTION
Information Only
Launch of Hizentra™ 20%, Subcutaneous Immune Globulin (Human)
2012-05 (PDF) 2012-01-26 Shipping Containers Utilized for RBC Shipments
2012-04 (PDF) 2012-01-25

Corporate Name Change for Talecris Biotherpeutics, Ltd & Redesigned Latex-free Stopper

Grifols product stopper redesign to address complaints related to latex-free stoppers used in 100, 50 and 25 mL formats (PDF)

Canadian Blood Services Name Change Letter (PDF)

2012-03 (PDF) 2012-01-23 Change in Distribution of Starches Part II
2012-02 (PDF) 2012-01-19

Launch of Hizentra™ 20%, Subcutaneous Immune Globulin (Human)

Hizentra, 20%, Subcutaneous Immune Globulin (human), 20% solution for injection (PDF)

2012-01 (PDF) 2012-01-09 Research Use of Blood Components

Back to top

2011

Letter # Date Title
2011-37 (PDF) 2011-12-02 Donor Red Cell Phenotyping Labelling
2011-36 (PDF) 2011-11-29 New Process for Issuing and Labelling of Deglycerolized RBC’s with Incomplete Testing/Donor Assessment
2011-35 (PDF) 2011-11-28 Canadian Blood Services’ Toronto Site Move to Brampton Facility
2011-34 (PDF) 2011-11-21 IVIG-Associated Hemolysis
2011-33 (PDF) 2011-11-15 Revised Process for Emergency Release of Blood Components
2011-32 (PDF) 2011-10-20

FEIBA NF (Anti-Inhibitor Coagulant Complex, Vapor Heated, Nanofiltered) EXPANDED TEMPERATURE STORAGE of 2°C to 25°C

FEIBA NF 1000U and 2500U formats now approved with expanded temperature storage of +2°C to +25°C (PDF)

2011-31 (PDF) 2011-10-12 Discontinuation of the CP2D Plasma Circular of Information
2011-30 (PDF) 2011-09-26 Changes to Canadian Blood Services Operations Medical On-Call Schedule Starting Week of October 3, 2011
2011-29 (PDF) 2011-09-20

Changes to Plasma Protein Products Distributed by Canadian Blood Services

IMPORTANT INFORMATION – 12 MONTHS ROOM TEMPERATURE STORAGE (PDF)

Introduction of the “Next Generation” Mix2VialTM into octaplex® Product Kits (PDF)

2011-28 (PDF) 2011-09-19 Canadian Guidelines for the Uniform Labelling of Blood and Blood Components Using ISBT 128
2011-27 (PDF) 2011-09-12

Changes to Physician’s Request for Directed Donation and Directed Donation Utilization Forms

Directed Donation Utilization Report (PDF)

Physician's Request for Directed Donation (PDF)

2011-26 (PDF) 2011-08-25 WinRho® SDF Product Information
Cangene Letter (PDF)
2011-25 (PDF) 2011-08-25 Implementation of New Label Material
2011-24 (PDF) 2011-08-25 Updates to the Clinical Guide to Transfusion, New On-line Edition
2011-23 (PDF) 2011-08-16 Circular of Information – Quality Control (QC) Criteria for Pooled Platelets LR CPD
2011-22 (PDF) 2011-08-15 Release of Plasma Component Circulars of Information – Change in Storage of Thawed Plasma from 24 Hours to 120 Hours (5 Days)
2011-21 (PDF) 2011-08-08 2011 Hospital Satisfaction Survey Summary
2011-20 (PDF) 2011-08-02

Availability of Beriplex® P/N (Human prothrombin complex)

Comparison Table (PDF)

Behring letter (PDF)

2011-19 (PDF) 2011-07-18 Donor Red Cell Phenotyping
2011-18 (PDF) 2011-07-14 Discontinuation of Printing Platelet Yields on Apheresis Platelet Labels
2011-17 (PDF) 2011-06-30

Important Information Regarding Phenotype Labelling Bug

Attachment (PDF)
2011-16 (PDF) 2011-06-30

Important Information Regarding - Extended ISBT 128 Label

Attachment (PDF)
2011-15 (PDF) 2011-06-28 Change in Distribution of Starches
2011-14 (PDF) 2011-06-27 Washed Red Blood Cells With Extended Expiry, Implementation Delay
2011-23 (PDF) 2011-06--27 CORRECTION - Expiration Time for Thawed Plasma (24 Hours vs. 5 Days)
2011-12
Correction (PDF)
2011-06-13 CORRECTION - Circular of Information – Quality Control (QC) Criteria for Pooled Platelets LR CPD
2011-13 (PDF) 2011-06-01 Talecris Stopper Redesign Project
Talecris Letter (PDF)
2011-12 (PDF) 2011-05-17 Circular of Information – Quality Control (QC) Criteria for Pooled Platelets LR CPD
2011-11 (PDF) 2011-05-03 New Label Material
2011-10 (PDF) 2011-04-14

Health Canada Endorsed Important Safety Information on Vivaglobin®

Behring letter (PDF)
2011-09 (PDF) 2011-04-14 Donor Testing Announcement - Transfer of Donor Testing from Halifax to Toronto
(Distributed to Atlantic Canada Facilities only)
2011-08 (PDF) 2011-03-14 Change to Move Dates to the New Brampton Facility
2011-07 (PDF) 2011-03-09 Important Information Regarding Availability of Immune Globulin Products for 2011-2012
2011-06 (PDF) 2011-03-03 Release of the Circulars of Information February 2011 Version
2011-05 (PDF) 2011-02-28

FEIBA NF (Anti-Inhibitor Coagulant Complex, Vapor Heated and Nanofiltered) Replaces FEIBA VH

Baxter letter (PDF)
2011-04 (PDF) 2011-02-22 CBS to Begin Labelling IgA Deficient SAGM Red Blood Cell Components
2011-03 (PDF) 2011-02-14 Introduction of MPX Testing (including HBV DNA)
2011-02 (PDF) 2011-01-31 Canadian Blood Services Evaluation of Current Use of Shipping Containers – Further Information
2011-01 (PDF) 2011-01-17 New Site Codes for Brampton and Dartmouth Facilities

Back to top

2010

Letter # Date Title
2010-43 (PDF) 2010-12-07

Gamunex® and IGIVnex® (Immune Globulin Intravenous [Human], 10%) Now Indicated for Subcutaneous (SC) Administration

Attachment (PDF)

2010-42 (PDF) 2010-12-01

F040275, Requisition for Antibody Investigation

Attachment (PDF)

2010-40 (PDF) 2010-11-30 Labels on Plasma Components
2010-41 (PDF) 2010-11-29 Maritime Facilities Redevelopment Project-Logistics Test Plan Information for New Brunswick Hospitals
2010-39 (PDF) 2010-11-10 Canadian Blood Services Evaluating Current Use of Shipping Containers
2010-38 (PDF) 2010-11-03

New Consignee Notification Form For Confirmatory / Supplementary Test Results

Attachment (PDF)
2010-37 (PDF) 2010-10-18

Hospital Satisfaction Survey Summary

Attachment (PDF)
2010-36 (PDF) 2010-10-12

Licensed Berinert® & Mix2Vial™Transfer Device

Behring Letter Jul. 19, 2010 (PDF)
Behring Letter Oct. 7, 2010 (PDF)
2010-35 (PDF) 2010-10-12 Production Trial of New Label Material
2010-34 (PDF) 2010-09-27

NiaStase RT® Activated Recombinant Human Blood Coagulation Factor VII Room Temperature Stable Now Available

Attachment (PDF)
2010-33 (PDF) 2010-09-23

Gammagard Liquid: New Vial Size

Attachment (PDF)
2010-32 (PDF) 2010-09-22 Circular of Information for AS-3 RBC and CP2D Platelet Components
2010-31 (PDF) 2010-09-20 Implementation of Fenwal Collection Sets/Automated Production Method at Canadian Blood Services – Saskatchewan Further Information
2010-30 (PDF) 2010-09-09 Further Information to Pediatric Platelet Transfusions and the Discontinuation of the Production of CP2D Platelets LR in Saskatchewan
2010-29 (PDF) 2010-08-19 Implementation of Fenwal Collection Sets/Automated Production Method at Canadian Blood Services – Saskatchewan UPDATE
2010-28 (PDF) 2010-08-10 Additional TRALI Reduction Measures for Plasma
2010-27 (PDF) 2010-07-28 Minor Modification to RBC Storage Container – Edmonton Site
2010-26 (PDF) 2010-07-27

Chagas Disease Lookback

Attachement (PDF)
2010-25 (PDF) 2010-07-19 WinRho SDF Product Information
Cangene Letter (PDF)
2010-24 (PDF) 2010-07-14

Important Information Regarding Updates to End Label for Double Components and New Héma-Québec Product Codes

Attachment 1 (PDF)

Attachment 2 (PDF)

Attachment 3 (PDF)

2010-23 (PDF) 2010-07-12 Expiration Time for Thawed Plasma (24 Hours vs. 5 Days)
2010-22 (PDF) 2010-07-05 Pediatric Platelet Transfusions and the Discontinuation of the Production of CP2D Platelets LR in Saskatchewan
2010-21 (PDF) 2010-06-29

Implementation of Fenwal Collection Sets/Automated Production Method at Canadian Blood Services – Saskatchewan

Procedure for Spiking New Buffy Coat Blood Bags (PDF)

2010-20 (PDF) 2010-06-28

Stability of Helixate® FS for Continuous Infusion

Behring letter (PDF)

2010-19 (PDF) 2010-06-09

CSL Behring’s Privigen® Shelf Life Extension

Behring letter (PDF)

2010-18 (PDF) 2010-06-09

NiaStase RT® Activated Recombinant Human Blood Coagulation Factor VII Room Temperature Stable is coming to Canada

NiaStase letter (PDF)

2010-17 (PDF) 2010-05-31 Packed Red Blood Cell Units from donors with Red Blood Cell Antibodies
2010-16 (PDF) 2010-05-27

Approved Use of BAXJECT II Hi-Flow Reconstitution Device with FEIBATM VH IMMUNO

Baxter letter (PDF)

2010-15 (PDF) 2010-05-18

Introducing a new choice for patients….the Kogenate® FS 3000 IU vial

Bayer Letter (PDF) 

2010-14 (PDF) 2010-05-06 Implementation of Fenwal Collection Sets/Automated Production Method at Canadian Blood Services – Saskatchewan
2010-13 (PDF) 2010-05-03 Circular of Information – CBS to Begin Selective Testing for Trypanosoma cruzi (T. cruzi) or Chagas Disease
2010-12 (PDF) 2010-04-14 Important Information Regarding Availability of Immune Globulin Products for 2010-2011
2010-11 (PDF) 2010-04-14 Further Implementation of Fenwal Blood Storage bags at Canadian Blood Services – Winnipeg
2010-10 (PDF) 2010-04-13

Humate-P® Made from Canadian Plasma and New Surgery Indication

Behring Letter (PDF)

FVIII/vWF Products Comparison Table (PDF)

2010-09 (PDF) 2010-03-29 Further Information Regarding Primary TRALI Reduction Measures
2010-08 (PDF) 2010-03-29

Association of WinRho® SDF ((Rho (D) Immune Globulin (Human)) with Intravascular Hemolysis in the Treatment of Immune Thrombocytopenic Purpura (ITP) – Important New Prescribing Information

Cangene letter (PDF)

2010-07 (PDF) 2010-03-08 Further Implementation of Fenwal Blood Storage Bags at Canadian Blood Services – Hamilton
2010-06 (PDF) 2010-02-23 Further Implementation of Fenwal Blood Storage bags at Canadian Blood Services – Toronto
2010-05 (PDF) 2010-02-11 Further Implementation of Fenwal Blood Storage bags at Canadian Blood Services
2010-04 (PDF) 2010-02-08

HepaGam B®

Cangene letter (PDF)

HepaGam B regulatory status update (PDF)

HBIg comparison table (PDF)

2010-03 (PDF) 2010-01-28

Changes to Plasma Protein Products Distributed by Canadian Blood Services

Reconstitution of Octaplex (PDF)

Behring letter (PDF)

2010-02 (PDF) 2010-01-18 Further Implementation of Fenwal Blood Storage bags at Canadian Blood Services – North Eastern Ontario and Nunavut
2010-01 (PDF) 2010-01-18

Compatibility of Talecris Latex-Free 20 mm Stoppers with Various Spiking Devices

Compatibility of Talecris latex-free 20 mm stoppers with various spiking devices (PDF)

Back to top

2009

Letter # Date Title
2009-29 (PDF) 2009-12-22 dvate® 3000 IU approved for distribution in Canada
Baxter letter (PDF)
2009-28 (PDF) 2009-12-08 Product Announcement: Xyntha™ (PDF)
2009-27 (PDF) 2009-12-01 Release of the Circulars of Information January 2009 Edition
2009-26 (PDF) 2009-12-07 Important Information Regarding ISBT 128 Donation Number Labels
2009-25 (PDF) 2009-10-26 Changes to Plasma Protein Products Distributed by Canadian Blood Services
Cytogam® Shelf Life Extension (PDF)
CSL Behring's Haemocomplettan® P-Fibrinogen Concentrate (PDF)
2009-24 (PDF) 2009-10-21 New TRALI Patient Data Form (PDF)
For more information about TRALI , please go to professionaleducation.blood.ca
2009-23 (PDF) 2009-10-19 Further Implementation of Fenwal Blood Storage bags at Canadian Blood Services
2009-22 (PDF) 2009-10-08 Privigen® Increased Infusion Speed (PDF)
Immune Globulin Comparison Table
2009-21 (PDF) 2009-10-05 Inventory Status Update and Pandemic Readiness
2009-20 (PDF) 2009-09-28
Minor Modification to RBC Storage Container
2009-19 (PDF) 2009-09-22 Important Information regarding the “Produced On” Date on CPD Platelets, Pooled, LR for Components
2009-18 (PDF) 2009-08-27 New sizes of frozen plasma storage cartons.
2009-12 (PDF) 2009-08-20 Important information regarding the 2004 Circular of Information
2009-17 (PDF) 2009-07-16 Changes to Plasma Protein Products Distributed by Canadian Blood Services
Baxter letter (PDF)

New 2000 IU vial size and NIPRO Safe Touch PSV 25 gauge butterfly for Helixate® FS (PDF)

Vivaglobin® Immune Globulin Subcutaneous is now available in 3ml vials (PDF)
2009-15 (PDF) 2009-06-18 Important Information Regarding ISBT 128 Implementation
2009-16 (PDF) 2009-06-17 Important Information Regarding Availability of Immune Globulin Products for 2009-2010
2009-07 (PDF) 2009-06-17 Important Information Regarding TRALI Reduction Measures
2009-09 (PDF) 2009-06-08 Important Information Regarding New Héma Québec Product Codes
2009-01 (PDF) 2009-05-25 Important Information Regarding Circulars of Information
2009-14 (PDF) 2009-05-19 Changes to Plasma Protein Products Distributed by Canadian Blood Services
Octaplex letter (PDF)
Wyeth letter (PDF)
2009-13 (PDF) 2009-05-14 Important Information Regarding ISBT128 Implementation
2009-11 (PDF) 2009-05-11 Information Regarding the Availability of the Visual Assessment Guide
2009-10 (PDF) 2009-03-31 Incompatibility of Talecris Latex-free Stoppers and FluVen Infusion Sets.
Talecris letter (PDF)
2009-08 (PDF) 2009-03-26 Important Information Regarding ISBT 128 Implementation
Attachment (PDF)
2009-06 (PDF) 2009-03-02 Changes to Plasma Protein Products Distributed by Canadian Blood Services.
Gamunex IGIV/nex approved by Health Canada for CIDP (PDF)

Humate-P Storage at room temperature (PDF)

Special Access Programs (Health Canada) (PDF)
2009-02 (PDF) 2009-02-15 Important Information Regarding IVIG-Associated Hemolysis
2009-05 (PDF) 2009-02-05 Updated Information Regarding the Availability of octaplex®
2009-04 (PDF) 2009-01-15 Availability of Vivaglobin® (Immune Globulin Subcutaneous [Human])
Immune Globulin Comparison Table (PDF)

Vivaglobin® available in January 2009 for Primary Immunodeficient patients throughout Canada (PDF)
2009-03 (PDF) 2009-01-09 Launch of PrivigenTM A new liquid, 10%, IVIG product>
CSL Behring plans to launch a new 10% IVIG in January 2009: Privigentm (PDF)

Back to Top

 

2008

Letter # Date Title
2008-29 (PDF) 2008-01-09 Important Information Regarding Double Platelet Collections – Follow-up
2008-28 (PDF) 2008-11-17 Important Information Regarding ISBT 128 Sample Labels and Product Codes
Attachments:
1 PDF),
2-1 (PDF),
2-2 (PDF),
2-3 (PDF),
2-4 (PDF),
2-5 (PDF),
2-6 (PDF),
2-7 (PDF),
2-8 (PDF),
2-9 (PDF)
2008-27 (PDF) 2008-10-15 Introduction of Privigentm
A new liquid, 10%, IVIG product
IVIG Comparison Table 2009-09-24 (PDF)
CSL Behring plans to launch Privigentm (PDF)
2008-23 (PDF) 2008-10-14 Discontinuing Distribution of Infusion Sets
2008-25 (PDF) 2008-09-26 Important information regarding double platelet collections
2008-24 (PDF) 2008-09-23 Availability of Synagis® (Palivizumab) 2008-2009
2008-26 (PDF) 2008-09-15 CORRECTION: Introduction of wilate® (Human coagulation factor VIII and human von Willebrand factor)
Wilate Letter (PDF)
2008-09 (PDF) 2008-08-11 Important Information Regarding a New Guideline for Investigation of Suspected Transfusion Transmitted Bacterial Contamination Available from the Public Health Agency of Canada
2008-22 (PDF) 2008-07-31 Important Information Regarding the Availability of octaplex®
2008-17 (PDF) 2008-07-24 Whole Blood Component Codes/Names Updates for the Buffy Coat Production Method
2008-21 (PDF) 2008-07-24 Changes to Recombinant Factor VIII & IX Products Distributed by Canadian Blood Services
Baxter Letter (PDF)
Bayer Letter (PDF)
Wyeth Letter (PDF)
2008-20 (PDF) 2008-07-17 Changes to Products Distributed by Canadian Blood Services:
1. Gamunex®/IGIVnex™ - Latex-free stoppers
2. Alburex® 5 – Availability of 500 mL vial size
Talecris Letter (PDF)
2008-19 (PDF) 2008-07-21 Important information regarding reduction of SAGM red blood cell minimum volume cut-off
2008-18 (PDF)
2008-06-20
Further Information Regarding Pre-1986/Post-1990 Hepatitis C Settlement Program
Refer to customer letter 2008-02 (PDF)
2008-07 (PDF) 2008-06-02 Important Information Regarding Circulars of Information: CBS to Begin using West Nile Virus (WNV)Nucleic Acid Testing (NAT) Licensed Test Kits
2008-16 (PDF) 2008-05-15 Changes to Products Distributed by Canadian Blood Services:
1. Advate® - Ancillary kit improvements
2. Berinert® P - Storage at room temperature & Administration kit
3. WinRho® SDF - New liquid formulation
Baxter Letter (PDF)
CSL Behring Letter (PDF)
Cangene Letter (PDF)
2008-15 (PDF) 2008-05-07 Important Information Regarding Availbility of IVIG Products for 2008-2009
2008-12 (PDF) 2008-05-06 Important Information Regarding New Equipment for Apheresis Platelet Collections
2008-14 (PDF) 2008-04-21 Important Information Regarding: Availability of Health Canada Licensed CytoGam®
CSL Behring Letter (PDF)
Products Table (PDF)
2008-13 (PDF) 2008-04-15 Introduction of wilate® (Human coagulation factor VIII and human von Willebrand factor)
Octapharma Letter (PDF)
Products Comparison Table (PDF)
2008-06 (PDF) 2008-04-09 Important Information Regarding ISBT 128 Planned Implementation at Canadian Blood Services
2008-11 (PDF) 2008-04-09 Introduction of octaplex® (Human Prothrombin Complex)
Octapharma Letter
2008-03 (PDF) 2008-04-07 Important Information Regarding Revisions to Blood Component and Blood Product Order Forms
2008-10 (PDF) 2008-03-27 Health Canada's Special Access Programme (SAP): New Request Forms
2008-08 (PDF) 2008-03-06 Recombinant Factor VIII Products Distributed by Canadian Blood Services
2008-02 (PDF) 2008-02-14 Important Information Regarding Pre-1986/Post-1990 Hepatitis C Settlement Program
2008-05 (PDF) 2008-02-06 Further Information Regarding Primary TRALI Reduction Measures
2008-04 (PDF) 2008-01-25 New Recall Manual - Hospital Follow-Up Customer Letter
Notification Form (PDF)
2008-01 (PDF) 2008-01-04 Important Information Regarding TRALI Laboratory Investigations
For the latest version of this form, please visit Hospital Customer Forms

Back to Top

2007

Letter # Date Title
2007-46 (PDF) 2007-12-17 Important Information Regarding: Completion of Recombinate Phase-out in Canada
Baxter Letter (PDF)
2007-45 (PDF) 2007-11-28 Important Information Regarding Medical Director London Centre, Canadian Blood Services
2007-44 (PDF) 2007-11-28 Important Information Regarding CPDA-1 Divided Products
2007-43 (PDF) 2007-11-14 CORRECTION: Introduction of Voluven®
Fresenius Kabi Pre-Letter (PDF)
Fresenius Kabi Letter re:Voluven® (PDF)
2007-34 (PDF) 2007-11-23 Important Information Regarding Platelets Apheresis, LR Product Update
2007-30 (PDF) 2007-11-23 Important Information Regarding the Release of the 2004 and 2005 Circulars of Information - Amendments for the new Platelets Apheresis, LR Transfusion Instructions Label
2007-39 (PDF) 2007-10-29 Introduction of HepaGam BTM (Hepatitis B Immune Globulin (Human) Injection)
HepaGam B Launch Package (PDF)
HBIg Comparison Table (PDF)
2007-38 (PDF) 2007-10-30 Important Information Regarding BeneFIX®
Wyeth Letter (PDF)
2007-37 (PDF) 2007-10-11 Important Information Regarding Humate P®
2007-42 (PDF) 2007-10-23 Update on Canadian Blood Services' Organizational Structure
2007-41 (PDF) 2007-10-23 Update on Canadian Blood Services' Organizational Structure
2007-40 (PDF) 2007-10-23 Update on Canadian Blood Services' Organizational Structure
2007-37 (PDF) 2007-10-11 Important Information Regarding Humate P ®
Humate P Letter (PDF)
2007-36 (PDF) 2007-10-10 Important Information Regarding Advate®
Notification of Advate® Packaging Changes (PDF)
2007-35 (PDF) 2007-09-27 Update on Canadian Blood Services Inventory Levels
2007-33 (PDF) 2007-09-27 Availability of Synagis® (Palivizumab)
Request Form (PDF)
2007-32 (PDF) 2007-09-19 Introduction of Voluven®
Fresenius Kabi Canada Letter - Deleted
See Customer Letter #2007-43 for further details
Comparison Table (PDF)
2007-29 (PDF) 2007-08-23 Update on Canadian Blood Services Inventory Levels
2007-28 (PDF) 2007-08-23 Update on CytoGam® Distribution via the Special Access Programme (SAP)
CytoGam® Update (PDF)
2007-24 (PDF) 2007-08-14 ISBT 128 Implementation at Héma-Québec
2007-27 (PDF) 2007-08-13 Important Information Regarding Current Canadian Blood Services Inventory Levels
2007-19 (PDF) 2007-08-10 Important Information Regarding Availability of IVIG Products for 2007-2008
Clinician GGL Notification Letter (PDF)
IVIG Comparison Table (PDF)
2007-15 (PDF) 2007-08-07 2005 Circular of Information for the Use of Human Blood and Blood Components - Booklet format for Buffy Coat Production Method
2007-25 (PDF) 2007-08-02 Important Information Regarding Primary TRALI Reduction Measures
2007-26 (PDF) 2007-07-27 Field Correction: Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized Humate-P
2007-18 (PDF) 2007-07-24 Important Information Regarding Change to ACD Fresh Frozen Plasma Apheresis Storage Bag
2007-23 (PDF) 2007-06-20 Important Information Regarding: Limited Availability of Albumin 25%
2007-21 (PDF) 2007-06-15 Important Information Regarding CytoGam® Requiring Temporary Special Access Programme (SAP) Authorization
Letter from CSL Behring Canada (PDF)
Revised Special Access Programme (SAP) Products Table (PDF)
2007-16 (PDF) 2007-05-08 Important Information Regarding Recombinate Antihemophilic Factor (Recombinant) (rAHF) Phase-out in Canada
Baxter Letter (PDF)
2007-14 (PDF) 2007-04-24 Important Information Regarding Infusion Rate Inconsistencies Found in the CytoGam® Product Monograph
CSL Behring Letter - CytoGam (PDF)
2007-13 (PDF) 2007-04-23 Introduction of New Pall Medical Red Cell Storage Bags
Questionnaire (PDF)
2007-12 (PDF) 2007-04-04 Corporate Name Change - CSL Behring Canada, Inc. and Revised Special Access Programme (SAP) Products Table
CSL Behring Letter (PDF)
Special Access Programme (PDF)
2007-11 (PDF) 2007-12-14 Manual Transformation Product Label
2007-03 (PDF) 2007-02-27 Further Reducing the Risk of Bacterial Contamination of Platelet Concentrates
Reference Material 1 (PDF)
Reference Material 2 (PDF)
2007-09 (PDF) 2007-02-26 Important Information Regarding Availability of VariZIGTM [Varicella Zoster Immune Globulin (Human) Lyophilized and its Reconstitution
2007-08 (PDF) 2007-02-19 Revisions to the Plasma Proteins Order Form
Sample: Plasma protein order form (PDF)
2007-10 (PDF) 2007-02-16 Revised Donation and Pool Number Labels
2007-05 (PDF) 2007-02-12 Changes to Blood Component Storage Containers
2007-07 (PDF) 2007-02-08 Implementation of a NewInventory Management System for Plasma Protein Products
2007-04 (PDF) 2007-02-01 ISBT 128 Implementation
2007-06 (PDF) 2007-01-26 Important Information Regarding Intravenous Immune Globulin (IVIG): Demand & Supply Trends and Utilization Guidelines
2007-02 (PDF) 2007-01-08 Bacterial Detection Testing
2007-01 (PDF) 2007-11-29 Important Information Regarding Notification of Component Recall/Withdrawal Form


Back to Top